Amita Shukla-Dave
Overview
Explore the profile of Amita Shukla-Dave including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
117
Citations
2384
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Shalom E, Kim H, van der Heijden R, Ahmed Z, Patel R, Hormuth 2nd D, et al.
Magn Reson Med
. 2023 Dec;
91(5):1803-1821.
PMID: 38115695
Purpose: has often been proposed as a quantitative imaging biomarker for diagnosis, prognosis, and treatment response assessment for various tumors. None of the many software tools for quantification are standardized....
12.
Akin O, Lema-Dopico A, Paudyal R, Konar A, Chenevert T, Malyarenko D, et al.
Cancers (Basel)
. 2023 Nov;
15(22).
PMID: 38001728
This review focuses on the principles, applications, and performance of mpMRI for bladder imaging. Quantitative imaging biomarkers (QIBs) derived from mpMRI are increasingly used in oncological applications, including tumor staging,...
13.
LoCastro E, Paudyal R, Konar A, LaViolette P, Akin O, Hatzoglou V, et al.
Tomography
. 2023 Nov;
9(6):2052-2066.
PMID: 37987347
There is a need to develop user-friendly imaging tools estimating robust quantitative biomarkers (QIBs) from multiparametric (mp)MRI for clinical applications in oncology. Quantitative metrics derived from (mp)MRI can monitor and...
14.
Jansen J, Paudyal R, Mazaheri Y, Shukla-Dave A
Front Oncol
. 2023 Sep;
13:1272030.
PMID: 37727204
No abstract available.
15.
Paudyal R, Shah A, Akin O, Do R, Konar A, Hatzoglou V, et al.
Cancers (Basel)
. 2023 May;
15(9).
PMID: 37174039
Cancer care increasingly relies on imaging for patient management. The two most common cross-sectional imaging modalities in oncology are computed tomography (CT) and magnetic resonance imaging (MRI), which provide high-resolution...
16.
Rogers H, Singh S, Barnes A, Obuchowski N, Margolis D, Malyarenko D, et al.
Eur J Radiol
. 2023 Apr;
162:110782.
PMID: 37004362
Purpose: VERDICT (Vascular, Extracellular, Restricted Diffusion for Cytometry in Tumours) MRI is a multi b-value, variable diffusion time DWI sequence that allows generation of ADC maps from different b-value and...
17.
Reyngold M, Karam S, Hajj C, Wu A, Cuaron J, Lobaugh S, et al.
Int J Radiat Oncol Biol Phys
. 2023 Mar;
117(1):53-63.
PMID: 36918130
Purpose: The optimal dose and fractionation of stereotactic body radiation therapy (SBRT) for locally advanced pancreatic cancer (LAPC) have not been defined. Single-fraction SBRT was associated with more gastrointestinal toxicity,...
18.
Romeo V, Stanzione A, Ugga L, Cuocolo R, Cocozza S, Quarantelli M, et al.
Insights Imaging
. 2022 Dec;
13(1):198.
PMID: 36528678
Background: The clinical role of perfusion-weighted MRI (PWI) in head and neck squamous cell carcinoma (HNSCC) remains to be defined. The aim of this study was to provide evidence-based recommendations...
19.
Konar A, Shah A, Paudyal R, Fung M, Banerjee S, Dave A, et al.
Cancers (Basel)
. 2022 Nov;
14(22).
PMID: 36428699
The purpose of the present pilot study was to estimate T1 and T2 metric values derived simultaneously from a new, rapid Magnetic Resonance Fingerprinting (MRF) technique, as well as to...
20.
Solomon E, Lemberskiy G, Baete S, Hu K, Malyarenko D, Swanson S, et al.
Magn Reson Med
. 2022 Oct;
89(2):522-535.
PMID: 36219464
Purpose: To assess the reliability of measuring diffusivity, diffusional kurtosis, and cellular-interstitial water exchange time with long diffusion times (100-800 ms) using stimulated-echo DWI. Methods: Time-dependent diffusion MRI was tested...